Hello, this is Kabu Times.In this issue, we cover Otsuka Holdings (4578), which handles pharmaceuticals and beverages such as ...
Otsuka just posted Q3 2026 earnings, and the stock closed the session at ¥4,352 after a choppy week that included a small ...
The stock prices of Japan's five major pharmaceutical companies have diverged. Over the one-year period from October 17, 2025, to October 16, 2026, Takeda Pharmaceutical, Otsuka Holdings (HD), and ...
Otsuka Holdings has delivered a powerful share price run in recent years, and the question now is whether the current ¥12,320 level can be explained by the cash the business is expected to generate.
Otsuka Holdings Co. ( OTSKF ,4578.T), a Japanese Pharmaceutical firm, Friday reported that its profit for nine months of fiscal 2026 increased from last year with higher revenues. Further, the firm ...
Detailed price information for Otsuka Holdings CO Ltd (OTSKF) from The Globe and Mail including charting and trades.
UBS kept its Buy rating and a JPY 15,000 12-month target for Otsuka Holdings on October 6, 2026, according to IT Boltwise. Against the Tokyo price of JPY 12,360 on October 20, 2026, that target stands ...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...
Otsuka Holdings Co., Ltd., a global healthcare group focused on pharmaceuticals, nutraceuticals, and consumer products, operates amid this transition through its portfolio of neuroscience, oncology, ...
Vera stock reversed course Tuesday despite positive results for its kidney disease treatment, a rival to drugs from Otsuka and Vertex Pharmaceuticals (VRTX). The company's drug, Trutakna, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results